Cookie notice

This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.
Find out more about how we use cookies and how to manage them by reading our cookie notice.

  • About our use of cookies
  • Go to navigation
  • Go to content
AstraZeneca Internationall

AstraZeneca Global

  • Investors
  • Media
  • Careers
  • Healthcare professionals
  • Patients

Other AZ websites

Quick Links

  • Calendar
  • Photo library
  • Media Contacts
  • Financial information
  • AstraZeneca in the US
  • AstraZeneca Annual Report 2012
  • Follow us on Twitter
  • AstraZeneca Careers Site
  • MedImmune

AstraZeneca Worldwide

Americas

  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Mexico
  • United States
  • Uruguay
  • Venezuela

Asia-Pacific

  • Australia
  • China
  • Hong Kong
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • The Philippines

Europe

  • Belgium
  • Bulgaria
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Middle East & North Africa

  • Turkey
  • Home
  • About Us
    • Our strategy
    • What we do
    • Key facts
    • Board & management
    • Social media
    • Features
    • Worldwide locations
    • History
    • Glossary of terms
  • Medicines
    • Cardiovascular
    • Gastrointestinal
    • Infection
    • Neuroscience
    • Oncology
    • Respiratory
    • Products A-Z
  • Research
    • Introduction
    • Capabilities
    • Our pipeline
    • Path to new medicines
    • Focus on disease
    • Collaborations
    • Events
    • Our global reach
    • Research news
    • R&D in the press
    • AstraZeneca Nobel Medicine Initiative
  • Partnering
    • What we offer partners
    • Our partnering process
    • Areas of interest
    • Regional opportunities
    • Contact us
    • Meet us at events
    • Case studies
    • Latest partnering news
  • Responsibility
    • Introduction
    • Sales & marketing practice
    • Access to healthcare
    • Research ethics
    • Human rights
    • Our people
    • Working with suppliers
    • Patient safety
    • The environment
    • Community investment
    • Governance & management
    • Code, policies & standards
    • Reporting performance
Investors
  • Corporate governance
  • Shareholder information
  • Investor tools
  • Financial information
  • Presentations & webcasts
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
    • 2002
    • 2001
    • 2000
    • 1999
  • SEC filings
  • Directors' shareholdings
  • Annual reports
  • Investor contacts

You are here

  • Investors
  • Presentations & webcasts
  • 2003

2003 Presentations

2003 full year results presentation

29 January 2004

Downloads

  • Presentation (PDF 241kb)

2003 annual business review

2 October 2003

Downloads

  • Introduction (PDF 43kb)
  • US pharma environment (PDF 1221kb)
  • US marketing (PDF 1206kb)
  • Statins (PDF 867kb)
  • Pipeline review (PDF 286kb)
  • Exanta (PDF 379kb)
  • Symbicort (PDF 246kb)
  • Iressa (PDF 450kb)
  • Conclusion (PDF 104kb)

2003 half year results presentation

24 July 2003

Downloads

  • Presentation (PDF 188kb)
  • Pipeline review (PDF 286kb)

2003 other presentations

17 October 2003

Downloads

  • 17 Oct 2003 - AstraZeneca operations (PDF 1102kb)
  • 18 Nov 2003 - CSFB pharma conference (PDF 1731kb)
Bookmark & Share

Legal Notices

  • Contact us
  • Legal notice and Terms of Use
  • Privacy notice
  • About our use of cookies
  • © AstraZeneca 2013

This website uses cookies. By continuing to use this website you consent to the use of cookies to enable functionality included in this website. You can understand more about our use of cookies on this page.

This website is intended for people seeking information on AstraZeneca's International business. We also have national business sites; links to these are under 'Other AZ websites' at the top of the page.